Improvement of clinical and MM findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy
- 30 November 1992
- journal article
- case report
- Published by Elsevier in Brain & Development
- Vol. 14 (6) , 409-412
- https://doi.org/10.1016/s0387-7604(12)80350-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Physiological significance of fatty acid elongation system in adrenoleukodystrophyJournal of the Neurological Sciences, 1991
- Adrenoleukodystrophy Associated with Cerebral Arteriovenous MalformationPediatrics International, 1990
- Reversal of Early Neurologic and Neuroradiologic Manifestations of X-Linked Adrenoleukodystrophy by Bone Marrow TransplantationNew England Journal of Medicine, 1990
- Dietary erucic acid therapy for X‐linked adrenoleukodystrophyNeurology, 1989
- A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patientsAnnals of Neurology, 1987
- Lignoceroyl‐CoASH ligase: enzyme defect in fatty acid β‐oxidation system in X‐linked childhood adrenoleukodystrophyFEBS Letters, 1986
- Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophyAnnals of Neurology, 1985
- Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.Journal of Clinical Investigation, 1983
- Abnormality of Long‐Chain Fatty Acids in Erythrocyte Membrane Sphingomyelin from Patients with AdrenoleukodystrophyJournal of Neurochemistry, 1981
- Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brainJournal of Neurochemistry, 1976